Mitotically Inactivated Stem Cells for Tissue Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for using embryonic stem cells (ESC) in tissue repair are hindered by the risk of teratoma formation and the need for lifelong immune suppression, which comes with significant side effects and lifestyle restrictions due to the potential for uncontrolled cell proliferation and immune system suppression.
Innovation Solution
Mitotically and/or lethally inactivating stem cells to prevent unlimited proliferation, allowing for their use in repairing damaged tissues without the need for permanent immune suppression, using methods such as irradiation or agents that inhibit cell division, thereby avoiding teratoma formation and reducing the need for immunosuppressive therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If embryonic stem cells are used for tissue repair, then tissue regeneration is achieved, but teratoma formation occurs due to uncontrolled cell proliferation
Solution Approach 1:
The stem cells are subjected to mitotic inactivation treatment (irradiation or chemical agents) before transplantation to prevent uncontrolled proliferation. This preliminary action eliminates the harmful effect of teratoma formation while preserving the beneficial tissue regeneration capability by inactivating only the mitotic potential, not the differentiation capacity.
Solution Approach 2:
The patent changes the biological state of stem cells from proliferative to non-proliferative through mitotic inactivation. This parameter change in cell cycle status allows the cells to maintain their differentiation potential while losing their ability to form tumors, resolving the contradiction between regeneration and teratoma formation.
2Reliability
If embryonic stem cells are transplanted, then tissue repair is achieved, but lifelong immune suppression is required to prevent rejection
Solution Approach 1:
The mitotically inactivated stem cells are designed to be transient and non-persistent in the host. They perform their regenerative function and then die out without requiring lifelong immune suppression. This approach trades permanent engraftment for temporary, sufficient action, eliminating the harmful need for continuous immunosuppression therapy.
3Object-generated harmful factors
If stem cells are differentiated ex vivo to prevent teratomas, then teratoma formation is avoided, but the process becomes time-consuming and requires extensive purification
Solution Approach 1:
Instead of differentiating stem cells ex vivo to eliminate teratoma risk (the conventional approach), the patent inverts the sequence by maintaining stem cells in their undifferentiated state and applying mitotic inactivation before transplantation. This inversion eliminates the time-consuming differentiation and purification processes while still preventing teratoma formation through inactivation of mitotic potential.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables effective tissue regeneration without the formation of teratomas and eliminates the requirement for lifelong immune suppression, improving patient comfort and quality of life by allowing transient chaperone-like effects for endogenous tissue repair, applicable across various organs and tissues without the need for extensive differentiation or purification processes.
Implementation Method 1
Mitotically and/or lethally inactivating stem cells to prevent unlimited proliferation, allowing for their use in repairing damaged tissues without the need for permanent immune suppression, using methods such as irradiation or agents that inhibit cell division
Data Source
AI summary
The present invention is directed to the use of mitotically and/or lethally inactivated stem cells for the repair of damaged organs and/or tissues. Stem cells are mitotically and/or lethally inactivated and transplanted into damaged tissue. Any form of ex vivo inactivation of stem cells may be used such that the stem cells cannot undergo mitosis or cell division before in vivo application. Mitotically and/or lethally inactivated stem may be used to ameliorate numerous disease, injury, traumatic, ischemic, aging, and/or degenerative conditions in different types of organs and/or tissues.